Development and Validation of a Nomogram for Predicting the Long-Term Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension

被引:3
|
作者
Hu, Song [1 ]
Tan, Jiang-Shan [1 ]
Liu, Sheng [2 ]
Guo, Ting-Ting [1 ]
Song, Wu [2 ]
Peng, Fu-Hua [1 ]
Wu, Yan [1 ]
Gao, Xin [1 ]
Hua, Lu [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Thrombosis Ctr,Natl Ctr Cardiovasc Dis,State Key, Natl Clin Res Ctr Cardiovasc Dis,Key Lab Pulm Vas, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Adult Cardiac Surg Ctr, Natl Ctr Cardiovasc Dis,Dept Cardiac Surg, Beijing, Peoples R China
来源
关键词
ARTERIAL-HYPERTENSION; RISK STRATIFICATION; MANAGEMENT; HYPOXIA;
D O I
10.1016/j.amjcard.2021.09.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There remains a lack of prognosis models for patients with chronic thromboembolic pulmonary hypertension (CTEPH). This study aims to develop a nomogram predicting 3-, 5-, and 7-year survival in patients with CTEPH and verify the prognostic model. Patients with CTEPH diagnosed in Fuwai Hospital were enrolled consecutively between May 2013 and May 2019. Among them, 70% were randomly split into a training set and the other 30% as a validation set for external validation. Cox proportional hazards model was used to identify the potential survival-related factors which were candidate variables for the establishment of nomogram and the final model was internally validated by the bootstrap method. A total of 350 patients were included in the final analysis and the median followup period of the whole cohort was 51.2 months. Multivariate analysis of Cox proportional hazards regression showed body mass index, mean right atrial pressure, N-terminal probrain natriuretic peptide (per 500 ng/ml increase in concentration), presence of anemia, and main treatment choice were the independent risk factors of mortality. The nomogram demonstrated good discrimination with the corrected C-index of 0.82 in the training set, and the C-index of 0.80 (95% CI: 0.70 to 0.91) in the external validation set. The calibration plots also showed a good agreement between predicted and actual survival in both training and validation sets. In conclusion, we developed an easy-to-use nomogram with good apparent performance using 5 readily available variables, which may help physicians to identify CTEPH patients at high risk for poor prognosis and implement medical interventions. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [21] Efficacy of ptpa for long-term outcome in chronic thromboembolic pulmonary hypertension
    Inami, T.
    Shigeta, Y.
    Kataoka, M.
    Fukushi, K.
    Takeuchi, K.
    Kikuchi, H.
    Yoshino, H.
    Satoh, T.
    EUROPEAN HEART JOURNAL, 2017, 38 : 550 - 551
  • [22] Long-Term Outcomes of Patients with Chronic Thromboembolic Pulmonary Hypertension at a Single Japanese Pulmonary Endarterectomy Center
    Miwa, H.
    Tanabe, N.
    Jujo, T.
    Kato, F.
    Anazawa, R.
    Yamamoto, K.
    Naito, A.
    Kasai, H.
    Nishimura, R.
    Sugiura, T.
    Sakao, S.
    Tatsumi, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [23] The long-term efficacy and therapeutic role of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
    Mizoguchi, H.
    Matsubara, H.
    Ogawa, A.
    Munemasa, M.
    Minatsuki, S.
    EUROPEAN HEART JOURNAL, 2011, 32 : 445 - 445
  • [24] Long-term Outcomes and Predictors of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy
    Sun, Shuai
    Li, Ji-Feng
    Liu, Lin
    Miao, Ran
    Yang, Su-Qiao
    Kuang, Tu-Guang
    Gong, Juan-Ni
    Gu, Song
    Liu, Yan
    Yang, Yuan-Hua
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [25] Long-term Outcomes and Predictors of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy
    Sun, Shuai
    Li, Ji-Feng
    Liu, Lin
    Miao, Ran
    Yang, Su-Qiao
    Kuang, Tu-Guang
    Gong, Juan-Ni
    Gu, Song
    Liu, Yan
    Yang, Yuan-Hua
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [26] Long-term outcome prediction for chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy
    Song, Wu
    Zhu, Jiade
    Zhong, ZhaoJi
    Song, Yunhu
    Liu, Sheng
    CLINICAL CARDIOLOGY, 2022, 45 (12) : 1255 - 1263
  • [27] Long-term Outcomes and Predictors of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy
    Sun, Shuai
    Li, Ji-Feng
    Liu, Lin
    Miao, Ran
    Yang, Su-Qiao
    Kuang, Tu-Guang
    Gong, Juan-Ni
    Gu, Song
    Liu, Yan
    Yang, Yuan-Hua
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [28] The long-term outcome of chronic thromboembolic pulmonary hypertension: Pulmonary endarterectomy and balloon pulmonary angioplasty
    Yang, Kuo-Ming
    Wang, Mei-Tzu
    Tao, Chi-Wei
    Wu, Yih-Jer
    Hsu, Chih-Hsin
    Liao, Wei-Chih
    Hsu, Hsao-Hsun
    Lin, Meng-Chih
    Tsai, Fu-Ting
    Fu, Yun-Ju
    Kuo, Feng-Yu
    Cheng, Chin-Chang
    Hung, Cheng-Chung
    Wang, Hao-Chien
    Yu, Chong-Jen
    Huang, Wei-Chun
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2024, 87 (03) : 273 - 279
  • [29] Prognostic nomogram for predicting long-term survival in patients with retroperitoneal liposarcoma
    Chen, J.
    Chen, Q.
    Zhou, J.
    EUROPEAN UROLOGY, 2022, 81 : S948 - S948
  • [30] Long-term safety and survival time under subcutaneous treprostinil treatment in patients with severe chronic thromboembolic pulmonary hypertension (CTEPH)
    Jansa, Pavel
    Sadushi-Kolici, Roela
    Kopec, Grzegorz
    Skoro-Sajer, Nika
    Halank, Michael
    Simkova, Iveta
    Steringer-Mascherbauer, Regina
    Salobir, Barbara
    Klepetko, Walter
    Lindner, Jaroslav
    Lang, Irene M.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62